Previous studies from our laboratory and others have demonstrated that pharmacologic activation of Nrf2 has beneficial effects in models of emphysema23, chronic obstructive pulmonary disease (COPD) exacerbation24, viral infection25, asthma26, sepsis27, 28, and radiation injury29. The gene discussed is NFE2L2; the disease is chronic obstructive pulmonary disease.